Indeed, in the original subtyping classification of glioblastomas [4], MEOX2 was initially reported as a marker of the CL subtype, and more recently, MEOX2 was shown to be aberrantly activated and one of the master transcription factors in Group 1 GSCs [27]. The gene discussed is MEOX2; the disease is glioblastoma.